Protocol Ledger

NCT06096259 · Phase II · RECRUITING

Preventing Injured Knees From osteoArthritis: Severity Outcomes

Interventional Phase II clinical trial protocol NCT06096259 sponsored by Brigham and Women's Hospital in Immunology, Rheumatology, and Dermatology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-05-06 Enrollment: 512 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06096259
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)512 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06096259
Protocol FieldVerified Registry Value
NCT IdentifierNCT06096259
Consolidated Lead SponsorBrigham and Women's Hospital
Therapeutic Condition CohortImmunology, Rheumatology, and Dermatology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment512 participants (ESTIMATED)
Registered Start Date2024-05-06
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Mass General Brigham across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI